Skip to main content
SpringerLink
Log in

Antimicrobial Resistance Among Epidemiologically Important Gram-Positive Bacteria

  • Chapter
  • First Online:
Management of Antimicrobials in Infectious Diseases

Part of the book series: Infectious Disease ((ID))

  • 1763 Accesses

Abstract

The emergence of antimicrobial resistance among clinically relevant bacteria has resulted in profound changes in the approach to treatment of infections caused by these pathogens. This chapter will focus on three epidemiologically important gram-positive bacteria: Streptococcus pneumoniae, Staphylococcus aureus, and Enterococcus species. Common infections due to these organisms, common resistance mechanisms, and available treatment options will be reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 269.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lee C, Banks SD, Li JP (1999). Virulence, immunity and vaccine related Streptococcus pneumoniae. Crit Rev Microbiol 18:89–114

    Article  Google Scholar 

  2. Ekdahl K, Ahlinder I, Hansson HB et al. (1997). Duration of nasopharyngeal carriage of penicillin-resistant Streptococcus pneumoniae: Experiences from South Swedish Pneumococcal Intervention Project. Clin Infect Dis 25:1113–1117

    Article  PubMed  CAS  Google Scholar 

  3. Fedson DS, Musher DM (2003). Pneumococcal vaccine. In: Plotkin SA, Orenstein WB (eds) Vaccines. Philadelphia: WB Saunders

    Google Scholar 

  4. Whitney CG, Farley MM, Hadler J, Harrison LH (2003). Decline in invasive pneumococcal disease after the Introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348:1737–1746

    Article  PubMed  Google Scholar 

  5. Whitney CG, Farley MM, Hadler J et al. (2000). Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 343:1917–1924

    Article  PubMed  CAS  Google Scholar 

  6. Doern GV, Richter SS, Miller A et al. (2005). Antimicrobial resistance among Streptococcus pneumoniae in the United States: Have we begun to turn the corner on resistance to certain antimicrobial classes? Clin Infect Dis 41:139–148

    Article  PubMed  CAS  Google Scholar 

  7. Waterer GW, Somes GW, Wunderink RG (2001). Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch Intern Med 161:1837–1842

    Article  PubMed  CAS  Google Scholar 

  8. Francis JS, Lopatin U et al. (2005). Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton Valentine leukocidin genes. Clin Infect Dis 40:100–107

    Article  PubMed  Google Scholar 

  9. National Nosocomial Infection Surveillance (NNIS) System (2004). National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32:470–485

    Google Scholar 

  10. Cosgrove SE, Sakoulas G, Perencevich EN et al. (2003). Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis. Clin Infect Dis 36:53–59

    Article  PubMed  Google Scholar 

  11. Engemann JJ, Carmeli Y, Cosgrove SE et al. (2003). Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 36:592–598

    Article  PubMed  Google Scholar 

  12. Fridkin SK, Hageman JC, Morrison M et al. (2005). Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 352:1436–1444

    Article  PubMed  CAS  Google Scholar 

  13. Moran GJ, Krishnadasan A, Gorwitz RJ et al. (2006). Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 355:666–674

    Article  PubMed  CAS  Google Scholar 

  14. Klevens RM, Morrison MA, Nadle J et al. (2007). Invasive methicillin-resistant Staphylococcus aureus infections in the United States. J Am Med Assoc 298:1763–1771

    Article  CAS  Google Scholar 

  15. Sharpe JN, Shively EH, Polk HC, Jr. (2005). Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. Am J Surg 189(4):425–428

    Article  PubMed  Google Scholar 

  16. Kollef MH, Rello J, Cammarata SK et al. (2004). Clinical cure and survival in gram-positive ventilator-associated pneumonia: Retrospective analysis of two double-blind studies comparing linezolid with vancomycin. Intensive Care Med 30(3):388–394

    Article  PubMed  Google Scholar 

  17. Rice LB (2006). Antimicrobial resistance in gram-positive bacteria. Am J Med 119:S11–S19

    Article  PubMed  CAS  Google Scholar 

  18. Sievert DM, Rudrik JT, Patel JB et al. (2008). Vancomycin-resistant Staphylococcus aureus in the United States, 2002–2006. Clin Infect Dis 46:668–674

    Article  PubMed  CAS  Google Scholar 

  19. Murray BE (2000). Vancomycin-resistant enterococcal infections. N Engl J Med 342:710–721

    Article  PubMed  CAS  Google Scholar 

  20. Carmeli Y et al. (2002). Health and economic outcomes of vancomycin-resistant enterococci. Arch Intern Med 162:2223–2238

    Article  PubMed  Google Scholar 

  21. Salgado CD, Farr BM (2003). Outcomes associated with vancomycin-resistant enterococci: A meta-analysis. Infect Control Hosp Epidemiol 24:690–698

    Article  PubMed  Google Scholar 

  22. Moellering RC (2003). Linezolid: The first oxazolidinone antimicrobial. Ann Intern Med 138:135–142

    PubMed  CAS  Google Scholar 

  23. Bradford PA (2004). Tigecycline: A first in class glycylcycline. Clin Microbiol Newsl 26:163–168

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Infectious Diseases, Medical University of South Carolina, Charleston, SC, USA

    Cassandra D. Salgado

Authors
  1. Cassandra D. Salgado
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cassandra D. Salgado .

Editor information

Editors and Affiliations

  1. Dept. Family Medicine, Medical University of South Carolina, Calhoun St. 295, Charleston, 29425, U.S.A.

    Arch G. Mainous III

  2. School of Medicine, University of California, Davis, Davis, 95616, U.S.A.

    Claire Pomeroy

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Salgado, C.D. (2010). Antimicrobial Resistance Among Epidemiologically Important Gram-Positive Bacteria. In: Mainous III, A., Pomeroy, C. (eds) Management of Antimicrobials in Infectious Diseases. Infectious Disease. Humana Press. https://doi.org/10.1007/978-1-60327-239-1_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-60327-239-1_2

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-60327-238-4

  • Online ISBN: 978-1-60327-239-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation